RECRUITING

Adaptation and Initial Evaluation of Transdiagnostic CBT for Anxious and Depressed Smokers

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

This study will look at the effectiveness of a new treatment protocol for anxious and depressed smokers. Participants with clinically significant anxiety or depression will receive either the standard smoking cessation treatment or the Unified Protocol for Smoking Cessation Treatment. This study will demonstrate that a single treatment protocol can effectively address both smoking and the complex emotional comorbidities that are widespread in smokers will provide a novel, impactful, and highly disseminable treatment option missing from today's smoking cessation arsenal.

Official Title

Adaptation and Initial Evaluation of Transdiagnostic CBT for Anxious and Depressed Smokers

Quick Facts

Study Start:2020-12-20
Study Completion:2024-02
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT03920137

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years to 65 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:Yes
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. Age 18 years or older
  2. Willing and able to provide informed consent
  3. Able to understand and follow study procedures
  4. Stable medical condition
  1. Pregnancy or breastfeeding
  2. Severe psychiatric disorders
  3. Active substance abuse
  4. Unstable medical conditions
  5. Inability to comply with study requirements

Contacts and Locations

Study Contact

Pam Nizio, B.S.
CONTACT
713-743-8056
HoustonAHRL@gmail.com

Principal Investigator

Michael Zvolensky, Ph.D.
PRINCIPAL_INVESTIGATOR
University of Houston
Matthew Gallagher, Ph.D.
STUDY_DIRECTOR
University of Houston

Study Locations (Sites)

University of Houston
Houston, Texas, 77204
United States

Collaborators and Investigators

Sponsor: University of Houston

  • Michael Zvolensky, Ph.D., PRINCIPAL_INVESTIGATOR, University of Houston
  • Matthew Gallagher, Ph.D., STUDY_DIRECTOR, University of Houston

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2020-12-20
Study Completion Date2024-02

Study Record Updates

Study Start Date2020-12-20
Study Completion Date2024-02

Terms related to this study

Additional Relevant MeSH Terms

  • Smoking Cessation